Academic Journals Database
Disseminating quality controlled scientific knowledge

Investigation of barriers to clinical practice guideline-recommended pharmacotherapy in the treatment of COPD.

Author(s): Price L | Billups SJ | Rice MA | Hartsfield C

Journal: Pharmacy Practice
ISSN 1885-642X

Volume: 5;
Issue: 2;
Start page: 74;
Date: 2007;
Original page

Keywords: Pulmonary Disease | Chronic Obstructive | Practice Guidelines | Drug Therapy | Patient Compliance | United States

Background: The adoption of clinical practice guideline recommendations for COPD is suboptimal. Determining the barriers to the implementation of these practice guidelines may help improve patient care.Objective: To determine whether barriers to the use of pharmacotherapy according to practice guidelines are related primarily to patient or prescriber factors.Methods: Retrospective cohort study. Members of a health maintenance organization identified as having spirometry-defined COPD ranging from stage II to IV. Electronic medical records were reviewed for documentation of the following: 1) patient affordability issues, 2) history of an adverse drug reaction, 3) history of inefficacy to therapy, and 4) prescription history.Results: A total of 111 medical records were reviewed. There were 51% of patients who had not filled medications that had been prescribed in accordance with guidelines and 43% did not have the guideline recommended medications prescribed in the previous year. Only 4% and 2% of patients had documented inefficacy and affordability issues, respectively. There were no reported cases of adverse drug reactions. Conclusions: This study provides insight to the acceptance of COPD treatment recommendations by patients and providers. Further research is needed to design interventions to reduce barriers and optimize COPD treatment.
Why do you need a reservation system?      Save time & money - Smart Internet Solutions